Metabolic research
01Quality sourced02Secure shipping
Phase 3 · Investigational 7 in stock
Metabolic research
Retatrutide
Investigational triple GIP/GLP-1/glucagon signaling with promising weight and cardiometabolic results in clinical trials.
Price$120USD
Add this item now, then send the complete order from your cart.
Research overview
Retatrutide
in context.
Retatrutide is a once-weekly investigational molecule designed to activate GIP, GLP-1, and glucagon receptors. Clinical research is evaluating how this three-pathway approach may influence weight, fat mass, glucose regulation, and broader cardiometabolic measures.
Research highlights
- 01Three complementary receptor pathways
- 02Advanced clinical development
- 03Weight and metabolic research
Product details
- Presentation
- 20 MG
- Availability
- Available now · 7
- Ordering
- Cart checkout with a ready-to-send order message
- Intended use
- Laboratory, analytical, or educational research
For research use only. Not for human or veterinary consumption. No dosage, administration, medical advice, or research protocols are provided.
Explore the catalog